Literature DB >> 29157396

Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States.

Erica Rivas-Rodríguez1, Lilyana Amezcua2.   

Abstract

Minorities in the United States such as African Americans and Hispanics may have more severe disease than non-Hispanic whites. Factors contributing to these disparities are reviewed. The variations in disability from non-Hispanic whites may be the result of differences in clinical presentation, genetic underpinnings, and sociocultural factors. Creating awareness and increasing participation in research studies may improve our understanding.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African American; Ethnicity; Genetic admixture; Health disparity; Hispanic; Race

Mesh：

Year:  2018        PMID： 29157396     DOI： 10.1016/j.ncl.2017.08.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN： 0733-8619            Impact factor:   3.806


  11 in total

1.  Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups.

Authors:  Daniela A Pimentel Maldonado; April Moreno; Mitzi J Williams; Lilyana Amezcua; Shawn Feliciano; Anita Williams; Daniel Machemer; Terrie Livingston; Monique LaRocque; Melissa Glim; Hollie Schmidt
Journal:  Int J MS Care       Date:  2021-01-12

Review 2.  Race and ethnicity on MS presentation and disease course.

Authors:  Lilyana Amezcua; Jacob L McCauley
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

Review 3.  Impact of sex hormones on immune function and multiple sclerosis development.

Authors:  María C Ysrraelit; Jorge Correale
Journal:  Immunology       Date:  2018-10-11       Impact factor: 7.397

4.  Experiences of African American Women with Multiple Sclerosis.

Authors:  Alexa Stuifbergen; Heather Becker; Carolyn Phillips; Shalonda Horton; Janet Morrison; Francisco Perez
Journal:  Int J MS Care       Date:  2020-04-16

5.  Feasibility of "Sit Less, Move More": An intervention for reducing sedentary behavior Among African Americans with MS.

Authors:  Jessica F Baird; Jeffer E Sasaki; Brian M Sandroff; Gary R Cutter; Robert W Motl
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-06-10

6.  Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course.

Authors:  R E Ventura; T Iizumi; T Battaglia; Menghan Liu; G I Perez-Perez; J Herbert; M J Blaser
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

7.  Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.

Authors:  Patricia Urbaneja; Isaac Hurtado-Guerrero; Miguel Ángel Hernández; Begoña Oliver-Martos; Celia Oreja-Guevara; Jesús Ortega-Pinazo; Ana Alonso; Francisco J Barón-López; Laura Leyva; Óscar Fernández; María Jesús Pinto-Medel
Journal:  J Clin Med       Date:  2020-07-26       Impact factor: 4.241

8.  Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis.

Authors:  Vicki Mercado; Deepa Dongarwar; Kristen Fisher; Hamisu M Salihu; George J Hutton; Fernando X Cuascut
Journal:  Biomedicines       Date:  2020-11-25

9.  Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).

Authors:  Annette F Okai; Lilyana Amezcua; Regina R Berkovich; Angel R Chinea; Keith R Edwards; Brian Steingo; Aljoeson Walker; Alan K Jacobs; Nadia Daizadeh; Mitzi J Williams
Journal:  Neurol Ther       Date:  2019-10-25

Review 10.  The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Authors:  Hannah M Kohl; Andrea R Castillo; Javier Ochoa-Repáraz
Journal:  Diseases       Date:  2020-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.